BioFuse Names Dr. Ralph Zipper as President and CEO

MELBOURNE, FL – March 23 2017.  BioFuse Medical Technologies Inc., a privately-held medical technology and surgical device company that has developed a unique radiofrequency (RF) vessel-sealing platform technology, announces the appointment of Ralph Zipper, MD to the roles of President and Chief Executive Officer.

Dr. Zipper joins the BioFuse team bringing 20 years of health care industry experience.  He has a long track record in product development and commercialization including IP portfolio growth, regulatory pathways, research and development, clinical trials, branding, salesforce training, marketing and advertising, and professional education.  He holds multiple patents for both medical methods and devices. Dr. Zipper has extensive experience offering expert consultation to both medical device and pharmaceutical start-ups and continues to provide consultation on regulatory processes, labeling, patent portfolio development, physician and sales force training, marketing and pelvic medicine and reconstructive surgery.

Zipper is a leading authority on urogynecology, including pelvic reconstructive surgery and incontinence. Over the last 20 years, he has pioneered new techniques in pelvic reconstruction and has trained over one thousand surgeons in his techniques of prolapse and incontinence surgery. He has developed numerous surgical techniques and is the inventor of the Incisionless Vaginal Rejuvenation® laser procedure, and he holds patents in light and laser therapy.  He has also been the key figure in the commercialization of numerous inventions and products in the areas of urinary incontinence and pelvic organ prolapse. He was the founder and CEO of two  innovative medical device companies..

Dr. Zipper’s comments on the BioFuse’s BioFusion™ technology: “The BioFusion™ platform, combined with strategic partner synergies, will enable our company to successfully commercialize its novel and disruptive products across numerous surgical applications. Our proprietary advanced energy platform will provide superior therapeutic options to patients and physicians, while driving clinical and economic value for all of our stakeholders in the healthcare ecosystem.”

Dr. Zipper is a graduate of the University of Connecticut and received his MD degree from The Mount Sinai School of Medicine of The City University of New York.  He completed his residency at The Johns Hopkins Hospital, Department of Gynecology and Obstetrics in Baltimore, Maryland and is board certified in Female Pelvic Medicine and Reconstructive Surgery.

About BioFuse Medical Technologies

BioFusion, the core technology developed by BioFuse Medical Technologies Inc., is an advanced high frequency electrosurgical system which incorporates a unique and proprietary method of controlling and delivering energy to and through the target tissue resulting in suture-less wound closure. In studies, BioFusion® tissue fusion has been shown to create stronger wound closure than sutures, and leaves no foreign bodies behind. BioFusion® encompasses the proprietary use of a three phase RF energy algorithm, optimized specifically for the high strength wound closure.  This wound closure has been shown to be stronger than any form of commercially available wound closure modality including sutures, staples and adhesives.

For more information, please visit: or email: